Quantum
Home > Boards > US OTC > Alternative Energy >

United Health Products, Inc. (UEEC)

UEEC RSS Feed
Add UEEC Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 11/19/2018 4:30:20 PM - Followers: 41 - Board type: Free - Posts Today: 4

United Health Products, Inc.

 

About United Health Products, Inc.

United Health Products, Inc. (UEEC) develops, manufactures, and markets a patented hemostatic gauze for the healthcare and wound care sectors. The product, HemoStyp(R), is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products, Inc. visit: www.unitedhealthproductsinc.com.

UEEC Security Details
Share Structure
Market Value1 $16,300,445 a/o Jun 18, 2014
Shares Outstanding 102,647,640 a/o Apr 15, 2014
Float 82,554,000 a/o Dec 31, 2012
Authorized Shares 150,000,000 a/o Mar 31, 2013
Par Value No Par Value

http://www.otcmarkets.com/stock/UEEC/profile
 

Who we are...

United Health Products develops, manufactures, and markets innovative products based on our proprietary hemostatic gauze core technology. Our products are distributed under the brand name HemoStyp®, and other private label names, to the trauma, dental, dialysis, and veterinary markets.

We are customer driven. We distribute our products worldwide and support our partners with ideas and solutions that will help them manage the health and safety of the people they serve. United Health Products is based in Westbury, New York and
our common stock trades under the symbol “UEEC". More about our company...

What we do...

We produce HemoStyp®, a bio-absorbable sterile gauze that will promote hemostasis almost instantly when applied to a cut or open wound. It is a patented hemostatic agent registered with the FDA to help control bleeding.

HemoStyp® contains no harmful chemicals, additives, or animal by-products and is easily removed from the wound with water or saline without compromising coagulation.

HemoStyp® is available in multiple sizes and configurations
to help control most types of bleeding including: abrasions, lacerations, and major cuts; nose bleeds; dental surgeries;
post dialysis treatment; and puncture wounds.
More about our products...


HemoStyp® is a water soluable hemostatic gauze that will produce hemostasis almost instantly when placed on a cut or open wound.
It does not contain harmful chemicals or animal by-products and is FDA registered to help stop bleeding. Once bleeding has stopped, HemoStyp® is easily removed from the wound with water or saline solution without compromising hemostasis.

HemoStyp® is extremely effective, inexpensive, and easy to use.
It is hypoallergenic and bacteriostatic and is available in multiple sizes and configurations to suit various needs and applications.


United Health Products, Inc. (UEEC) was formed to develop, produce, and market proprietary wound care products. Our core technology is a hemostatic gauze that provides the means to control bleeding from cuts and open wounds with a cost effective, high efficiency product.

This innovative technology is derived from regenerated oxidized cellulose and marketed under the trade name HemoStyp®. It is an effective, all natural hemostatic agent registered with the FDA to help control bleeding from open wounds and body cavities.

HemoStyp® is available in multiple sizes and configurations to suit various market segments and, in a healthcare sector shifting toward providing high quality care at affordable cost, offers an appealing alternative to higher priced competitive products. In addition to general military and civilian applications, the company has recently introduced Hemostyp® to the sports medicine, veterinary, dental surgery and dialysis markets.

UEEC's Chairman and CEO, Dr. Phillip Forman, has over 30 years of experience in wound care management. He leads an experienced executive management team with proven ability to develop, integrate, and grow brands in the healthcare industry. Under Dr. Forman's leadership the company will focus on market expansion, distribution, and brand awareness through:

• New contracts and strategic partnerships
• Effectively targeted marketing and advertising
• Sales excellence
• Outstanding customer support
• Key acquisitions and
• Innovative product development



New Products

We have added new configuations of our patented hemostatic gauze to our product line. The products were developed to address the specific needs of new market segments and of our existing customers, including the U.S. Military. The new products include:

Dental Gauze for oral surgery,

Four versions of Trauma Gauze™ for battlefield trauma, and

Two island dressings to support intravenous procedures.

We expect tangible contributions from all of these products as well as from the cumulative effect of an expanded product line. We will continue to identify and develop new products and configurations as we explore new markets and inundate existing ones.

 

Quantum
UEEC
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
UEEC News: Quarterly Report (10-q) 04:04 PM
UEEC News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 11/15/2018 04:02:18 PM
UEEC News: Current Report Filing (8-k) 10/01/2018 03:18:06 PM
UEEC News: Quarterly Report (10-q) 08/20/2018 05:18:35 PM
UEEC News: Initial Statement of Beneficial Ownership (3) 08/16/2018 06:06:45 AM
News News Alert: Quarterly Report (10-q) 11/19/2018 04:04:06 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#1759   Hard to watch this performance day after day csterner 11/19/18 04:30:19 PM
#1758   Dam you are Orel himself. Great to The_Pro 11/19/18 04:23:39 PM
#1757   Got BIEL. Would be nice to see DR5 11/19/18 04:19:00 PM
#1756   Your biel and quantum if you own this rodman 11/19/18 03:23:37 PM
#1755   Yeah, looks like some good news may be DR5 11/16/18 01:09:09 PM
#1754   Quarterly 10Q report was extended... rodman 11/16/18 01:00:58 PM
#1753   Hey Waiting....I agree! I’ve always agreed with DR5 11/14/18 11:26:04 AM
#1752   You guys are still missing Trust's point. Waiting21 11/14/18 11:24:19 AM
#1751   Yeah, had a senior moment...lol...saw that after I DR5 11/14/18 11:09:36 AM
#1750   Agreed just stating what merger/acquisition's are occurring. rodman 11/14/18 10:59:25 AM
#1749   I just DREAM!! at least 10$ or more Chrism0000 11/14/18 10:48:26 AM
#1748   In this case, I would disagree. Pharma DR5 11/14/18 10:36:26 AM
#1747   Timing is everything I suspect UEEC will issue rodman 11/14/18 09:32:43 AM
#1746   Yeah, definitely market manipulation but the volume was DR5 11/13/18 04:05:05 PM
#1745   Fake run up by flippers and short sellers? rodman 11/13/18 03:38:37 PM
#1744   Hmmm seems like a lot of shares being Chrism0000 11/13/18 03:07:28 PM
#1743   I was wondering the same. hmmmm what's going on? Chrism0000 11/13/18 03:01:44 PM
#1742   Guess maybe I missed the update? .69 and climbing! rodman 11/13/18 01:42:01 PM
#1741   Let it ride below .60 one more time rodman 11/13/18 11:50:38 AM
#1740   i SHOULD TAKE OUT A BANK LOAN TO Chrism0000 11/12/18 02:29:33 PM
#1739   Your right on IMO! Broker to broker manipulation rodman 11/12/18 11:15:22 AM
#1738   I think this will drop at least 5 Chrism0000 11/12/18 11:03:12 AM
#1737   Nice! DR5 11/12/18 10:52:18 AM
#1736   50k pickup there thank you! rodman 11/12/18 09:34:55 AM
#1735   oops the no was wrong my misstake! rodman 11/10/18 01:14:11 PM
#1734   Yes and no estimated primary 11/19 and final rodman 11/10/18 01:09:10 PM
#1733   Copied this from the trial outline: Estimated Study Start DR5 11/10/18 11:21:08 AM
#1732   I thought the human trials does not finish Chrism0000 11/10/18 10:44:20 AM
#1731   I suspect the large pharm. Will or even rodman 11/10/18 08:18:19 AM
#1730   This company, if sold, will likely be bought Waiting21 11/10/18 08:09:40 AM
#1729   That type of money does not help me Chrism0000 11/10/18 01:05:31 AM
#1728   Sounds responsible Rod. I also feel $3-$5 is JHOGG 11/09/18 05:56:30 PM
#1727   At $3 a share you will still be rodman 11/09/18 12:29:01 PM
#1726   Sure hope your right Trust LVC 11/08/18 11:06:15 PM
#1725   I think it’s very possible to get closer DR5 11/07/18 10:08:14 AM
#1724   No, you don't understand economics. Think about trusttheman 11/07/18 09:58:04 AM
#1723   I hope Trust is right and $5 ends rodman 11/07/18 09:51:27 AM
#1722   I agree with Rodman... The market cap at band aid 11/07/18 09:46:28 AM
#1721   Apparently UHP does not understand economics or there rodman 11/07/18 08:45:11 AM
#1720   Some people never learn and just don't comprehend trusttheman 11/07/18 04:14:39 AM
#1719   trusttheman 11/07/18 04:14:38 AM
#1718   Chrism0000 11/06/18 05:17:07 PM
#1717   I hope it's worth more than ROKU a Chrism0000 11/06/18 05:10:57 PM
#1716   This product will be used all over the Chrism0000 11/06/18 05:08:42 PM
#1715   Lets be realistic the buyout will be nothing rodman 11/06/18 02:57:18 PM
#1714   YEA!!! 3 to 6 $ is an INSULT!! Chrism0000 11/06/18 02:08:30 PM
#1713   Agree. Waiting21 11/06/18 12:48:39 PM
#1712   Again. Irrelevant. I can't believe people are trusttheman 11/06/18 12:14:52 PM
#1711   4 million out of approx 180 million or Waiting21 11/06/18 08:18:58 AM
#1710   I have patience or would not continue to rodman 11/06/18 08:15:31 AM
PostSubject